Article Information
History
- December 5, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Richard K. Babbs1,
- Jacob A. Beierle1,2,3,
- Julia C. Kelliher1,
- Rose Medeiros1,4,
- Jeya Anandakumar1,4,
- Anyaa Shah1,
- Emily J. Yao1,
- Melanie M. Chen1 and
- Camron D. Bryant1,*
- 1Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, 72 E. Concord St., L-606C, Boston, MA 02118 USA
- 2Biomolecular Pharmacology Ph.D. Program, Boston University School of Medicine
- 3Boston University’s Transformative Training Program in Addiction Science (TTPAS), Biomedical Genetics, Boston University School of Medicine, 72 E. Concord St., E-200, Boston, MA 02118 USA
- 4National Institute on Drug Abuse Diversity Scholars Program, 6001 Executive Boulevard, Room 3105, MSC 9567, Bethesda, MD USA 20892-9567
- ↵*Corresponding Author
Camron D. Bryant, Ph.D., Director, Laboratory of Addiction Genetics, Associate Professor, Department of Pharmacology and Experimental Therapeutics and Psychiatry, 72 E. Concord St., L-606C, Boston, MA 02118, E: camron{at}bu.edu, P: (617) 638-4489, F: (617) 638-4329